HomeNewsDrug Discovery & Development

Asymchem opens R&D site near Boston, Massachusetts

Asymchem opens R&D site near Boston, Massachusetts

Asymchem Laboratories, a leading CDMO serving the global pharmaceutical and biotech industry, announced the opening of a new site in Woburn, Massachusetts – Asymchem Boston, a wholly-owned subsidiary of Asymchem Group, as an important step to expand Asymchem's global footprint. The new Boston site is focussed on providing early-stage R&D services including chemical process development, pre-formulation study and formulation development for small molecules, peptides, and oligonucleotides.

After establishing the location in August 2022, the site is now ready for full operation. Currently, there are 6000 sq ft of existing lab space that includes process and analytical labs, and space to expand in an additional 4500 sq ft. Solid characterization and pre-formulation labs will be ready in Q1 2023. By Q3 2023 continued expansion will include a fully functional kilo-lab, formulation R&D, and oligonucleotide and peptide lab to support drug substance and drug product development and non-GMP production.

Asymchem Boston not only provides direct service to biotech clients, but also serves as a liaison between its China-based manufacturing sites and the company's partners. Though the site's current focus is on small molecules, it will soon engage with more oligonucleotide and peptide work within the next year. From medicinal chemistry support to IND-enabling, the site will be equipped with the capacity to assist in early-stage process development for both drug substances and drug products.

"Asymchem has been working diligently in recent years to bring biotech clients an even more well-rounded CMC experience when managing early-stage projects. The company's expansion to Boston has become an integral part of this journey to better serve Asymchem's national and global partners," said, Dr Hao Hong, CEO, Asymchem Group.

More news about: drug discovery & development | Published by Sudeep Soparkar | December - 20 - 2022 | 233

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology